XERS US Equity
Xeris Biopharma Holdings, Inc.Health Care · Pharmaceutical Preparations · CIK 1867096 · FY ends Dec 31$8.70
+0.10 (+1.16%)
USD · as of 2026-08-21 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 9.2M |
| % of shares out | 5.1% |
| Days to cover | 6.8 |
| Δ vs 2026-07-15 | -8.5% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 9,221,405 | -8.5% | 1,366,174 | 6.8 |
| 2026-07-15 | 10,078,469 | -21.0% | 2,299,463 | 4.4 |
| 2026-06-30 | 12,760,034 | -0.4% | 2,343,847 | 5.4 |
| 2026-06-15 | 12,810,046 | +2.4% | 1,746,604 | 7.3 |
| 2026-05-29 | 12,514,253 | +1.2% | 1,328,898 | 9.4 |
| 2026-05-15 | 12,364,664 | -22.2% | 2,131,991 | 5.8 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
